Saxonov Serge 4
4 · 10x Genomics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Saxonov Serge
DirectorChief Executive Officer
Transactions
- Sale
Class A Common Stock
[F1][F2]2026-03-02$22.67/sh−14,292$323,985→ 1,205,527 total - Sale
Class A Common Stock
[F1][F3]2026-03-02$23.18/sh−1,860$43,111→ 1,203,667 total - Gift
Class A Common Stock
2026-03-03−2,750→ 1,200,917 total
Holdings
- 27(indirect: See footnote)
Class A Common Stock
[F4] - 213,250(indirect: See footnote)
Class A Common Stock
[F5] - 58,000(indirect: See footnote)
Class A Common Stock
[F6]
Footnotes (6)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $22.15 to $23.145, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $23.15 to $23.25, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- [F5]The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- [F6]The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
Signature
/s/ Randy Wu, as Attorney-in-Fact for Serge Saxonov|2026-03-04